MACM
AGN

March Altus Capital Management’s Allergan Inc AGN Stock Holding History

March Altus Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-32,336
Closed -$5.47M – 35
2014
Q2 		$5.47M Sell
32,336
-64,291
-67% -$10M 2.01% 24
2014
Q1 		$12M Sell
96,627
-9,018
-9% -$1.1M 3.85% 8
2013
Q4 		$11.7M Buy
+105,645
New +$10.1M 3.55% 12

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

March Altus Capital Management's AGN Position: Q3 2014 in Review

March Altus Capital Management sold out of Allergan Inc (AGN) in Q3 2014, closing a stake of 32,336 shares — an estimated $5.47M sold.

March Altus Capital Management first reported a position in AGN in Q4 2013 and held it in 3 quarters. The position peaked at $12M in Q1 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • March Altus Capital Management reported no remaining Allergan Inc position as of Q3 2014 after selling out during the quarter.
  • March Altus Capital Management sold 32,336 Allergan Inc shares in Q3 2014, an estimated $5.47M.
  • March Altus Capital Management first reported a position in Allergan Inc in Q4 2013 and held it in 3 quarters.
  • March Altus Capital Management's Allergan Inc position peaked at $12M in Q1 2014.
  • 749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on March Altus Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.